Stay updated on STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:13:40.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A site-wide NIH notice was added about website transition updates and terminology changes, and the site revision advanced from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:18:55.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:36:40.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a standard header and a Home link, indicating the study record is currently blocked from access.
    Difference
    19%
    Check dated 2026-09-23T00:15:49.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.6.6 to v3.7.0, indicating a newer build of the ClinicalTrials.gov page. No substantive study details appear to be altered in this update.
    Difference
    0.1%
    Check dated 2026-09-15T23:30:40.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page's revision history now includes Revision: v3.6.6 and removes Revision: v3.6.5, reflecting a small backend or page-tracking update rather than new study information.
    Difference
    0.1%
    Check dated 2026-09-01T20:23:25.000Z thumbnail image

Stay in the know with updates to STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STRO-002 Combo with Bevacizumab in Ovarian Cancer Clinical Trial page.